• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海蛇凝血酶原激活物:从矛头蝮蛇蛇毒中提取的外切Tenase 复合物对因子 X 激活的特异性抑制剂。

Exactin: A specific inhibitor of Factor X activation by extrinsic tenase complex from the venom of Hemachatus haemachatus.

机构信息

Department of Biological Sciences, Faculty of Science, National University of Singapore, Singapore 119260, Singapore.

Department of Biochemistry, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298, USA.

出版信息

Sci Rep. 2016 Aug 25;6:32036. doi: 10.1038/srep32036.

DOI:10.1038/srep32036
PMID:27558950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4997346/
Abstract

Unwanted clots lead to heart attack and stroke that result in a large number of deaths. Currently available anticoagulants have some drawbacks including their non-specific actions. Therefore novel anticoagulants that target specific steps in the coagulation pathway are being sought. Here we describe the identification and characterization of a novel anticoagulant protein from the venom of Hemachatus haemachatus (African Ringhals cobra) that specifically inhibits factor X (FX) activation by the extrinsic tenase complex (ETC) and thus named as exactin. Exactin belongs to the three-finger toxin (3FTx) family, with high sequence identity to neurotoxins and low identity to the well-characterized 3FTx anticoagulants-hemextin and naniproin. It is a mixed-type inhibitor of ETC with the kinetic constants, Ki' and Ki determined as 30.62 ± 7.73 nM and 153.75 ± 17.96 nM, respectively. Exactin does not bind to the active site of factor VIIa and factor Xa based on its weak inhibition (IC50 ≫ 300 μM) to the amidolytic activities of these proteases. Exactin shows exquisite macromolecular specificity to FX activation as compared to factor IX activation by ETC. Exactin thus displays a distinct mechanism when compared to other anticoagulants targeting ETC, with its selective preference to ETC-FX [ES] complex.

摘要

不想要的血栓会导致心脏病发作和中风,从而导致大量死亡。目前可用的抗凝剂存在一些缺点,包括它们的非特异性作用。因此,正在寻找针对凝血途径特定步骤的新型抗凝剂。在这里,我们描述了从 Hemachatus haemachatus(非洲环颈眼镜蛇)毒液中鉴定和表征新型抗凝蛋白,该蛋白特异性抑制外源性 tenase 复合物(ETC)激活因子 X(FX),因此命名为 exactin。Exactin 属于三指毒素(3FTx)家族,与神经毒素具有高度序列同一性,与特征明确的 3FTx 抗凝剂-hemextin 和 naniproin 具有低同一性。它是 ETC 的混合类型抑制剂,动力学常数 Ki' 和 Ki 分别确定为 30.62 ± 7.73 nM 和 153.75 ± 17.96 nM。基于其对这些蛋白酶的酶解活性的弱抑制作用(IC50>300 μM),Exactin 不会与因子 VIIa 和因子 Xa 的活性位点结合。与 ETC 激活因子 IX 相比,Exactin 对 FX 激活具有出色的大分子特异性。因此,与其他针对 ETC 的抗凝剂相比,Exactin 显示出独特的机制,其对 ETC-FX [ES] 复合物具有选择性偏好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1221/4997346/30f442dac2de/srep32036-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1221/4997346/3dc6b7a8d9a2/srep32036-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1221/4997346/08c39e1ad468/srep32036-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1221/4997346/aa3257e5fdba/srep32036-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1221/4997346/ac3ea930213f/srep32036-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1221/4997346/5f430b64fcda/srep32036-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1221/4997346/f7add33355f2/srep32036-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1221/4997346/30f442dac2de/srep32036-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1221/4997346/3dc6b7a8d9a2/srep32036-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1221/4997346/08c39e1ad468/srep32036-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1221/4997346/aa3257e5fdba/srep32036-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1221/4997346/ac3ea930213f/srep32036-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1221/4997346/5f430b64fcda/srep32036-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1221/4997346/f7add33355f2/srep32036-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1221/4997346/30f442dac2de/srep32036-f7.jpg

相似文献

1
Exactin: A specific inhibitor of Factor X activation by extrinsic tenase complex from the venom of Hemachatus haemachatus.海蛇凝血酶原激活物:从矛头蝮蛇蛇毒中提取的外切Tenase 复合物对因子 X 激活的特异性抑制剂。
Sci Rep. 2016 Aug 25;6:32036. doi: 10.1038/srep32036.
2
Hemextin AB complex, a unique anticoagulant protein complex from Hemachatus haemachatus (African Ringhals cobra) venom that inhibits clot initiation and factor VIIa activity.血纤蛋白AB复合物,一种源自黑颈射毒眼镜蛇(非洲环斑眼镜蛇)毒液的独特抗凝血蛋白复合物,可抑制凝血起始和因子VIIa活性。
J Biol Chem. 2005 Dec 30;280(52):42601-11. doi: 10.1074/jbc.M508987200. Epub 2005 Oct 4.
3
Ringhalexin from Hemachatus haemachatus: A novel inhibitor of extrinsic tenase complex.来自黑曼巴蛇(Hemachatus haemachatus)的环蛇毒素:一种新型外源性凝血酶原酶复合物抑制剂。
Sci Rep. 2016 May 13;6:25935. doi: 10.1038/srep25935.
4
Crystallization and preliminary X-ray diffraction analysis of hemextin A: a unique anticoagulant protein from Hemachatus haemachatus venom.血毒素A的结晶及初步X射线衍射分析:一种来自角蝰毒液的独特抗凝血蛋白。
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2007 Aug 1;63(Pt 8):701-3. doi: 10.1107/S1744309107034239. Epub 2007 Jul 21.
5
Hemextin AB complex--a snake venom anticoagulant protein complex that inhibits factor VIIa activity.Hemextin AB复合物——一种抑制因子VIIa活性的蛇毒抗凝血蛋白复合物。
Pathophysiol Haemost Thromb. 2005;34(4-5):184-7. doi: 10.1159/000092420.
6
Proteomic and toxinological characterization of the venom of the South African Ringhals cobra Hemachatus haemachatus.南非环蛇 Hemachatus haemachatus 毒液的蛋白质组学和毒素特性分析。
J Proteomics. 2018 Jun 15;181:104-117. doi: 10.1016/j.jprot.2018.04.007. Epub 2018 Apr 12.
7
Biophysical characterization of anticoagulant hemextin AB complex from the venom of snake Hemachatus haemachatus.来自黑曼巴蛇毒液的抗凝血血红蛋白AB复合物的生物物理特性
Biophys J. 2007 Dec 1;93(11):3963-76. doi: 10.1529/biophysj.106.100164. Epub 2007 Aug 17.
8
Evolutionary Adaptations in Pseudonaja Textilis Venom Factor X Induce Zymogen Activity and Resistance to the Intrinsic Tenase Complex.拟蛇纹石毒素因子 X 的进化适应性诱导酶原活性和对固有凝血酶复合物的抗性。
Thromb Haemost. 2020 Nov;120(11):1512-1523. doi: 10.1055/s-0040-1715441. Epub 2020 Aug 20.
9
Substrate delivery mechanism and the role of membrane curvature in factor X activation by extrinsic tenase.底物递送机制以及膜曲率在外源性凝血酶原酶激活因子X中的作用。
J Theor Biol. 2017 Dec 21;435:125-133. doi: 10.1016/j.jtbi.2017.09.015. Epub 2017 Sep 19.
10
Identification and characterisation of novel inhibitors on extrinsic tenase complex from Bungarus fasciatus (banded krait) venom.眼镜蛇科环蛇属(银环蛇)毒液中外源性凝血酶原酶复合物新型抑制剂的鉴定与表征
Thromb Haemost. 2014 Oct;112(4):700-15. doi: 10.1160/TH13-12-1063. Epub 2014 Jul 10.

引用本文的文献

1
Venom-derived peptides for breaking through the glass ceiling of drug development.用于突破药物研发瓶颈的毒液衍生肽。
Front Chem. 2024 Sep 26;12:1465459. doi: 10.3389/fchem.2024.1465459. eCollection 2024.
2
Blood Lines: Intraspecific and Interspecific Variations in Anticoagulant Actions of Viperid Venoms.血液线索:蛇毒抗凝作用的种内和种间变化。
Toxins (Basel). 2024 Jun 26;16(7):291. doi: 10.3390/toxins16070291.
3
The Clot Thickens: Differential Coagulotoxic and Cardiotoxic Activities of Anguimorpha Lizard Venoms.

本文引用的文献

1
Ringhalexin from Hemachatus haemachatus: A novel inhibitor of extrinsic tenase complex.来自黑曼巴蛇(Hemachatus haemachatus)的环蛇毒素:一种新型外源性凝血酶原酶复合物抑制剂。
Sci Rep. 2016 May 13;6:25935. doi: 10.1038/srep25935.
2
Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data.直接口服抗凝剂的特异性解毒剂:临床试验数据的全面综述
Int J Cardiol. 2016 Jul 1;214:292-8. doi: 10.1016/j.ijcard.2016.03.056. Epub 2016 Mar 28.
3
Profiles of direct oral anticoagulants and clinical usage-dosage and dose regimen differences.
血栓形成加剧:蚓蜥毒液的差异化凝血毒性和心脏毒性活性。
Toxins (Basel). 2024 Jun 20;16(6):283. doi: 10.3390/toxins16060283.
4
Snake Venom Components as Therapeutic Drugs in Ischemic Heart Disease.蛇毒成分在缺血性心脏病中的治疗药物作用。
Biomolecules. 2023 Oct 18;13(10):1539. doi: 10.3390/biom13101539.
5
Intramuscular Bleeding and Formation of Microthrombi during Skeletal Muscle Damage Caused by a Snake Venom Metalloprotease and a Cardiotoxin.蛇毒金属蛋白酶和心脏毒素引起的骨骼肌损伤中的肌内出血和微血栓形成。
Toxins (Basel). 2023 Aug 28;15(9):530. doi: 10.3390/toxins15090530.
6
Three finger toxins of elapids: structure, function, clinical applications and its inhibitors.眼镜蛇科动物的三种神经毒素:结构、功能、临床应用及其抑制剂。
Mol Divers. 2024 Oct;28(5):3409-3426. doi: 10.1007/s11030-023-10734-3. Epub 2023 Sep 25.
7
State-of-the-art review - A review on snake venom-derived antithrombotics: Potential therapeutics for COVID-19-associated thrombosis?前沿综述 - 蛇毒来源的抗血栓药物综述:COVID-19 相关血栓形成的潜在治疗方法?
Int J Biol Macromol. 2021 Dec 1;192:1040-1057. doi: 10.1016/j.ijbiomac.2021.10.015. Epub 2021 Oct 14.
8
Bioactive Molecules Derived from Snake Venoms with Therapeutic Potential for the Treatment of Thrombo-Cardiovascular Disorders Associated with COVID-19.蛇毒来源的生物活性分子具有治疗 COVID-19 相关血栓心血管疾病的潜力。
Protein J. 2021 Dec;40(6):799-841. doi: 10.1007/s10930-021-10019-4. Epub 2021 Sep 9.
9
Role of crotoxin in coagulation: novel insights into anticoagulant mechanisms and impairment of inflammation-induced coagulation.响尾蛇毒素在凝血中的作用:对抗凝机制及炎症诱导凝血损伤的新见解。
J Venom Anim Toxins Incl Trop Dis. 2020 Nov 27;26:e20200076. doi: 10.1590/1678-9199-JVATITD-2020-0076. eCollection 2020.
10
Mechanisms Responsible for the Anticoagulant Properties of Neurotoxic Venoms: A Viscoelastic Analysis.神经毒素毒液抗凝特性的作用机制:粘弹性分析。
Int J Mol Sci. 2020 Mar 18;21(6):2082. doi: 10.3390/ijms21062082.
直接口服抗凝剂的特点及临床应用-用法和剂量方案的差异。
J Intensive Care. 2016 Mar 10;4:19. doi: 10.1186/s40560-016-0144-5. eCollection 2016.
4
A Distinct Functional Site in Ω-Neurotoxins: Novel Antagonists of Nicotinic Acetylcholine Receptors from Snake Venom.Ω-神经毒素中的一个独特功能位点:来自蛇毒的烟碱型乙酰胆碱受体新型拮抗剂
ACS Chem Biol. 2015 Dec 18;10(12):2805-15. doi: 10.1021/acschembio.5b00492. Epub 2015 Oct 15.
5
Pros and cons of new oral anticoagulants.新型口服抗凝剂的利弊
Hematology Am Soc Hematol Educ Program. 2013;2013:464-70. doi: 10.1182/asheducation-2013.1.464.
6
Molecular determinants of phospholipid synergy in blood clotting.血液凝固中磷脂协同作用的分子决定因素。
J Biol Chem. 2011 Jul 1;286(26):23247-53. doi: 10.1074/jbc.M111.251769. Epub 2011 May 11.
7
Haemostatically active proteins in snake venoms.蛇毒中的止血活性蛋白。
Toxicon. 2011 Apr;57(5):627-45. doi: 10.1016/j.toxicon.2011.01.006. Epub 2011 Jan 26.
8
Complex assemblies of factors IX and X regulate the initiation, maintenance, and shutdown of blood coagulation.多种因子 IX 和 X 复合物调节着血液凝固的启动、维持和终止。
Prog Mol Biol Transl Sci. 2011;99:51-103. doi: 10.1016/B978-0-12-385504-6.00002-6.
9
Anticoagulants from hematophagous animals.来自吸血动物的抗凝剂。
Expert Rev Hematol. 2008 Dec;1(2):135-9. doi: 10.1586/17474086.1.2.135.
10
Structural and functional characterization of a novel homodimeric three-finger neurotoxin from the venom of Ophiophagus hannah (king cobra).新型同源二聚体三指神经毒素的结构与功能表征,该毒素来源于 Ophiophagus hannah(眼镜王蛇)的毒液。
J Biol Chem. 2010 Mar 12;285(11):8302-15. doi: 10.1074/jbc.M109.074161. Epub 2010 Jan 13.